EP1241945A4 - Immunotherapie et diagnostic du cancer utilisant du cytochrome p450 1b1 - Google Patents
Immunotherapie et diagnostic du cancer utilisant du cytochrome p450 1b1Info
- Publication number
- EP1241945A4 EP1241945A4 EP00980436A EP00980436A EP1241945A4 EP 1241945 A4 EP1241945 A4 EP 1241945A4 EP 00980436 A EP00980436 A EP 00980436A EP 00980436 A EP00980436 A EP 00980436A EP 1241945 A4 EP1241945 A4 EP 1241945A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- cytochrome
- diagnosis
- cancer immunotherapy
- immunotherapy
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000012466 Cytochrome P450 1B1 Human genes 0.000 title 1
- 108050002014 Cytochrome P450 1B1 Proteins 0.000 title 1
- 238000002619 cancer immunotherapy Methods 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001154—Enzymes
- A61K39/001157—Telomerase or TERT [telomerase reverse transcriptase]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4612—B-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464454—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464454—Enzymes
- A61K39/464457—Telomerase or [telomerase reverse transcriptase [TERT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/26—Universal/off- the- shelf cellular immunotherapy; Allogenic cells or means to avoid rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16559099P | 1999-11-15 | 1999-11-15 | |
US165590P | 1999-11-15 | ||
PCT/US2000/031513 WO2001035810A2 (fr) | 1999-11-15 | 2000-11-15 | Immunotherapie et diagnostic du cancer utilisant du cytochrome p450 1b1 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1241945A2 EP1241945A2 (fr) | 2002-09-25 |
EP1241945A4 true EP1241945A4 (fr) | 2005-08-17 |
Family
ID=22599560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00980436A Withdrawn EP1241945A4 (fr) | 1999-11-15 | 2000-11-15 | Immunotherapie et diagnostic du cancer utilisant du cytochrome p450 1b1 |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1241945A4 (fr) |
CA (1) | CA2390882A1 (fr) |
WO (1) | WO2001035810A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3941002A (en) * | 2000-10-31 | 2002-06-03 | Zycos Inc | Cyp1b1 nucleic acids and methods of use |
GB0223696D0 (en) * | 2002-10-14 | 2002-11-20 | Ml Lab Plc | Improved immunotherapy |
WO2004067549A2 (fr) * | 2003-01-31 | 2004-08-12 | Max-Delbrück-Centrum für Molekulare Medizin | Peptides diriges contre des autoanticorps resultant de l'intolerance au froid, et leur utilisation |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997012246A1 (fr) * | 1995-09-25 | 1997-04-03 | University Of Aberdeen | Proteine p450 specifique de tumeurs |
WO2000056773A1 (fr) * | 1999-03-19 | 2000-09-28 | The University Court Of The University Of Aberdeen | Anticorps specifiques de cyp1b1 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000025813A1 (fr) * | 1998-10-29 | 2000-05-11 | Dana-Farber Cancer Institute | IMMUNOTHERAPIE ET DIAGNOSTIC DU CANCER AU MOYEN D'ANTIGENES UNIVERSELS ASSOCIES A DES TUMEURS TELS QUE hTERT |
-
2000
- 2000-11-15 EP EP00980436A patent/EP1241945A4/fr not_active Withdrawn
- 2000-11-15 CA CA002390882A patent/CA2390882A1/fr not_active Abandoned
- 2000-11-15 WO PCT/US2000/031513 patent/WO2001035810A2/fr not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997012246A1 (fr) * | 1995-09-25 | 1997-04-03 | University Of Aberdeen | Proteine p450 specifique de tumeurs |
WO2000056773A1 (fr) * | 1999-03-19 | 2000-09-28 | The University Court Of The University Of Aberdeen | Anticorps specifiques de cyp1b1 |
Also Published As
Publication number | Publication date |
---|---|
CA2390882A1 (fr) | 2001-05-25 |
EP1241945A2 (fr) | 2002-09-25 |
WO2001035810A3 (fr) | 2002-01-10 |
WO2001035810A2 (fr) | 2001-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3617600A (en) | Human breast and ovarian cancer associated gene sequences and polypeptides | |
AU2002316576A1 (en) | Diagnostic and screening methods for bladder cancer | |
EP1474528A4 (fr) | Procedes de diagnostic du cancer de la prostate, compositions et procedes de criblage de modulateurs du cancer de la prostate | |
HK1083771A1 (en) | Anti-neovasculature preparations for cancer | |
GB2371747B (en) | Metal-containing compositions, preparations and uses | |
EP1511476A4 (fr) | Ligands macrocycliques pendants de type scorpionates, complexes et compositions contenant ces derniers, et leurs procedes d'utilisation | |
AU6476000A (en) | Mouse having human cytochrome p450 transferred therein | |
AU1465801A (en) | Methods for cancer prognosis and diagnosis | |
IL131662A0 (en) | Cytochrome p450 monooxygenases | |
AU3391200A (en) | Compositions and methods for breast cancer therapy and diagnosis | |
EP1110908A4 (fr) | Procede de synthese de l'hydroxyapatite, et complexe d'hydroxyapatite et son procede de preparation | |
PL335643A1 (en) | P450 cytochrome mono-oxygenases | |
AU2608201A (en) | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use | |
AU2002342053A1 (en) | Pancreatic cancer diagnosis and therapies | |
EP1241945A4 (fr) | Immunotherapie et diagnostic du cancer utilisant du cytochrome p450 1b1 | |
AU1083501A (en) | Antibiotic-metal complex and methods | |
AU5909400A (en) | Slide lock and report cover | |
AU1540101A (en) | Distortion reduction | |
AU7634900A (en) | Digital rosary | |
AU2001271284A1 (en) | Compositions and methods for the therapy and diagnosis of pancreatic cancer | |
AU2001283463A1 (en) | Methods of diagnosis of cancer and screening for cancer modulators | |
MXPA02004785A (es) | Citocromo p450 oxigenasas y sus usos. | |
AU5632500A (en) | Cancer associated antigens and uses therefor | |
AU2002305138A1 (en) | Methods and materials for cancer treatment | |
AU3742500A (en) | Ligands, transition metal complexes and methods of using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20020614 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: MAECKER, BRITTA Inventor name: SHERR, DAVID Inventor name: VON BERGWELT-BAILDON, MICHAEL Inventor name: NADLER, LEE, M. Inventor name: SCHULTZE, JOACHIM, L. Inventor name: VONDERHEIDE, ROBERT, H. |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 01N 63/00 A, 7A 61K 39/00 B, 7C 12N 1/20 B, 7C 12N 15/85 B |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: VON BERGWELT-BAILDON, MICHAEL Inventor name: SCHULTZE, JOACHIM, L., ATABIS GMBH Inventor name: NADLER, LEE, M. Inventor name: MAECKER, BRITTA Inventor name: SHERR, DAVID Inventor name: VONDERHEIDE, ROBERT, H. |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20050704 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20060515 |